MERRIMACK PHARMACEUTICALS INC Quarterly Common Stock, Shares, Issued from Q4 2011 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Merrimack Pharmaceuticals Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2011 to Q1 2024.
  • Merrimack Pharmaceuticals Inc Common Stock, Shares, Issued for the quarter ending March 31, 2024 was 14.5M shares, a 1.94% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 14.5M +277K +1.94% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 14.4M +136K +0.96% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 14.3M +911K +6.79% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 14.3M +911K +6.79% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 14.3M +845K +6.3% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 14.2M +805K +6% Dec 31, 2022 10-K 2024-03-07
Q3 2022 13.4M 0 0% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 13.4M 0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 13.4M 0 0% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 13.4M +30K +0.22% Dec 31, 2021 10-K 2023-03-09
Q3 2021 13.4M +30K +0.22% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 13.4M +30K +0.22% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 13.4M +30K +0.22% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 13.4M 0 0% Dec 31, 2020 10-K 2022-03-09
Q3 2020 13.4M +17K +0.13% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 13.4M +31K +0.23% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 13.4M +37K +0.28% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 13.4M +37K +0.28% Dec 31, 2019 10-K 2021-03-10
Q3 2019 13.4M +20K +0.15% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 13.3M +6K +0.05% Jun 30, 2019 10-Q 2019-07-17
Q1 2019 13.3M 0 0% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 13.3M 0 0% Dec 31, 2018 10-K 2020-03-12
Q3 2018 13.3M +69K +0.52% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 13.3M -119M -89.9% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 13.3M -119M -89.9% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 13.3M +323K +2.48% Dec 31, 2017 10-K 2019-03-06
Q3 2017 13.3M -116M -89.7% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 133M +3.75M +2.91% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 132M +15.5M +13.3% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 13M +1.43M +12.4% Dec 31, 2016 10-K 2018-03-12
Q3 2016 129M +14.3M +12.5% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 129M +18.2M +16.4% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 116M +7.03M +6.42% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 11.6M -95.1M -89.1% Dec 31, 2015 8-K 2017-12-15
Q3 2015 115M +9.45M +8.94% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 111M +6.29M +6.01% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 109M +6.03M +5.83% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 107M +4.17M +4.07% Dec 31, 2014 10-K 2016-02-26
Q3 2014 106M +3.38M +3.31% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 105M +8.15M +8.46% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 103M +7.41M +7.73% Mar 31, 2014 10-Q 2014-05-06
Q4 2013 103M +6.7M +6.99% Dec 31, 2013 10-K 2015-02-27
Q3 2013 102M +8.25M +8.77% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 96.4M +2.82M +3.02% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 95.9M +95.9M +805712% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 95.8M +84M +710% Dec 31, 2012 10-K 2014-03-04
Q3 2012 94M Sep 30, 2012 10-Q 2012-11-14
Q2 2012 93.5M Jun 30, 2012 10-Q 2012-08-14
Q1 2012 11.9K* Mar 31, 2012 10-Q 2012-05-15
Q4 2011 11.8M Dec 31, 2011 10-K 2013-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.